Clinical trial

Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.

NCT05820633

Drugs and interventions used in this trial

8 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

RADIATION · Unmapped registry intervention Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS) Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Report and compare changes in a non-inferiority analysis of the expanded prostate cancer index composite" (EPIC-26): Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Report and compare changes in a non-inferiority analysis of the Sexual Health Inventory for Men (SHIM) Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Report and compare changes in a non-inferiority analysis of the toxicities reported according to the Common Terminology Criteria for Adverse Events (CTCAE) Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Report and compare the biochemical disease free survival (bDFS) Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Report and compare the disease free survival (DFS) Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Report and compare the metastase free survival (MFS) Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Report and compare the overall survival (OS) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.

Design: INTERVENTIONAL · Status: SUSPENDED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusSUSPENDED

Study typeINTERVENTIONAL

Start date2022-09-01

PhaseNA

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Node; Prostateunresolved

Radiotherapy Side Effectunresolved

Interventions

Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)RADIATION

Report and compare changes in a non-inferiority analysis of the expanded prostate cancer index composite" (EPIC-26):RADIATION

Report and compare changes in a non-inferiority analysis of the Sexual Health Inventory for Men (SHIM)RADIATION

Report and compare changes in a non-inferiority analysis of the toxicities reported according to the Common Terminology Criteria for Adverse Events (CTCAE)RADIATION

Report and compare the biochemical disease free survival (bDFS)RADIATION

Report and compare the disease free survival (DFS)RADIATION

Report and compare the metastase free survival (MFS)RADIATION

Report and compare the overall survival (OS)RADIATION

Sponsors & collaborators

CHU de Quebec-Universite Lavallead sponsor

TerSera Therapeutics LLCcollaborator

Mapped research locations

MontrealQuebec, Canada2 SherbrookeQuebec, Canada1 QuébecCanada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05820633 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.